Covid-19: India logs highest cases in 146 days with 1590 new infections | Check active cases tally
India | Mar 25, 2023, 11:34 AM ISTCovid-19 in India: With six more fatalities, the death toll due to the viral disease has gone up to 5,30,824.
Covid-19 in India: With six more fatalities, the death toll due to the viral disease has gone up to 5,30,824.
India on Friday reported over 1200 new COVID-19 cases and two deaths in the last 24 hours.
World Bank presidential nominee Ajay Banga tested COVID-19 positive during routine testing in New Delhi. He is currently quarantined in isolation.
The daily positivity was recorded at 1.46 per cent while the weekly positivity was pegged at 1.08 per cent.
Covid review meet: Prime Minister Narendra Modi held a high-level meeting to review the Covid-related situation and public health preparedness, amid rising cases in the country.
According to the health ministry data, the daily positivity was recorded at 2.08 per cent while the weekly positivity was pegged at 0.86 per cent.
The XBB 1.16 variant was first found in January when two samples tested positive for the variant while in February a total of 59 samples were found. In March, till now 15 samples of the XBB 1.16 variant have been found.
The Centre has advised these states to monitor the situation of Covid cases at micro-level and maintain focus on implementation of necessary measures for prompt and effective management of the disease, duly ensuring effective compliance with various advisories issued by the Ministry of Health.
The overall death, toll ever since pandemic first hit the country, has increased to 5,30,781 with one new fatality reported in Kerala, government data said.
Coronavirus: Centre stressed the rising cases of H3N2 and raised concern over a gradual increase in the COVID-19 positivity rate amid rising seasonal influenza subtype H3N2.
The Huanan market in central China's Wuhan city was the epicentre of the pandemic. From its origin there, the SARS-CoV-2 virus rapidly spread to other locations in Wuhan in late 2019 and then to the rest of the world.
COVID-19 origins: Research into the root cause of coronavirus outbreak was important as it could have helped scientists prepare better to tackle any such future outbreaks.
COVID-19 was known to affect respiratory, gastrointestinal, cardiovascular and other systems, but there were very few studies describing liver involvement and liver function test (LFT) abnormalities, he said.
The Drug Controller General of India (DCGI) on January 16 approved market authorisation to Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin.
COVID-19 vaccine: iNCOVACC, the world's first intranasal COVID-19 vaccine, was launched on January 26 (Thursday). The vaccine is now available on CoWIN and priced at Rs 800 for private markets and Rs 325 for the government of India and state governments.
COVID19: The biosensors would be a one-step identification or sensing technique.
As children haven't been exposed to many viruses, their immune system is still 'naive'. And because they don't develop memory T cells, they are at risk of getting sick when they become reinfected
Several people who had new or existing heart disease and stroke symptoms were reluctant to seek medical care, particularly in the early days of the COVID pandemic.
Covid19 in China: China revealed that the country had recorded close to 60,000 Covid-related deaths in early and mid-December, 2022.
By analysing samples from COVID-19 convalescent individuals, the researchers found that some had antibodies specific for the coldspots, the study said.
Top News
Latest News